Autologous Cell Therapy Product Market

Autologous Cell Therapy Product Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

156

Base Year:

2022

Feb - 2022

Format:

Report Code:

VMR-1298

Segments Covered

By Source Bone Marrow, Epidermis
By End User Hospitals, Ambulatory Centers, Research Centers
By Application Cancer, Neurodegenerative Diseases, Wound Healing, Orthopedic, CVD, Autoimmune Diseases
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2022
Forecast Years:	2023 - 2030
Historical Years:	2017 - 2021
Revenue 2022:	USD 11.69 Billion
Revenue 2030:	USD 40.77 Billion
Revenue CAGR (2023 - 2030):	16.90%
Fastest Growing Region (2023 - 2030)	Asia Pacific
Largest Region (2022):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Autologous Cell Therapy Product Market - Segment Analysis
1. Overview
2. Global Autologous Cell Therapy Product Market, 2016 - 2028 (USD Million)
3. Global Autologous Cell Therapy Product Market - by Source
  1. By Bone Marrow
  2. By Epidermis
4. Global Autologous Cell Therapy Product Market - by End User
  1. By Hospitals
  2. By Ambulatory Centers
  3. By Research Centers
5. Global Autologous Cell Therapy Product Market - by Application
  1. By Cancer
  2. By Neurodegenerative Diseases
  3. By Wound Healing
  4. By Orthopedic
  5. By CVD
  6. By Autoimmune Diseases
6. Global Autologous Cell Therapy Product Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
7. Market comparative analysis
North America Autologous Cell Therapy Product Market - Segment Analysis
1. Overview
2. North America Autologous Cell Therapy Product Market, 2016 - 2028 (USD Million)
3. North America Autologous Cell Therapy Product Market, by Source
  1. By Bone Marrow
  2. By Epidermis
4. North America Autologous Cell Therapy Product Market, by End User
  1. By Hospitals
  2. By Ambulatory Centers
  3. By Research Centers
5. North America Autologous Cell Therapy Product Market, by Application
  1. By Cancer
  2. By Neurodegenerative Diseases
  3. By Wound Healing
  4. By Orthopedic
  5. By CVD
  6. By Autoimmune Diseases
6. North America Autologous Cell Therapy Product Market, by Country
  1. U.S.
    1. U.S. Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. U.S. Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. U.S. Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
  2. Canada
    1. Canada Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. Canada Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. Canada Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
  3. Mexico
    1. Mexico Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. Mexico Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. Mexico Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
Europe Autologous Cell Therapy Product Market - Segment Analysis
1. Overview
2. Europe Autologous Cell Therapy Product Market, 2016 - 2028 (USD Million)
3. Europe Autologous Cell Therapy Product Market, by Source
  1. By Bone Marrow
  2. By Epidermis
4. Europe Autologous Cell Therapy Product Market, by End User
  1. By Hospitals
  2. By Ambulatory Centers
  3. By Research Centers
5. Europe Autologous Cell Therapy Product Market, by Application
  1. By Cancer
  2. By Neurodegenerative Diseases
  3. By Wound Healing
  4. By Orthopedic
  5. By CVD
  6. By Autoimmune Diseases
6. Europe Autologous Cell Therapy Product Market, by Country
  1. Germany
    1. Germany Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. Germany Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. Germany Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
  2. UK
    1. UK Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. UK Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. UK Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
  3. France
    1. France Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. France Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. France Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
  4. Spain
    1. Spain Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. Spain Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. Spain Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
  5. Italy
    1. Italy Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. Italy Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. Italy Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
  6. BENELUX
    1. BENELUX Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. BENELUX Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. BENELUX Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
  7. Rest of Europe
    1. Rest Of Europe Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. Rest Of Europe Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. Rest Of Europe Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
Asia Pacific Autologous Cell Therapy Product Market - Segment Analysis
1. Overview
2. Asia Pacific Autologous Cell Therapy Product Market, 2016 - 2028 (USD Million)
3. Asia Pacific Autologous Cell Therapy Product Market, by Source
  1. By Bone Marrow
  2. By Epidermis
4. Asia Pacific Autologous Cell Therapy Product Market, by End User
  1. By Hospitals
  2. By Ambulatory Centers
  3. By Research Centers
5. Asia Pacific Autologous Cell Therapy Product Market, by Application
  1. By Cancer
  2. By Neurodegenerative Diseases
  3. By Wound Healing
  4. By Orthopedic
  5. By CVD
  6. By Autoimmune Diseases
6. Asia Pacific Autologous Cell Therapy Product Market, by Country
  1. China
    1. China Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. China Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. China Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
  2. Japan
    1. Japan Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. Japan Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. Japan Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
  3. India
    1. India Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. India Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. India Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
  4. South Korea
    1. South Korea Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. South Korea Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. South Korea Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
  5. South East Asia
    1. South East Asia Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. South East Asia Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. South East Asia Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. Rest of Asia Pacific Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. Rest of Asia Pacific Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
Latin America Autologous Cell Therapy Product Market - Segment Analysis
1. Overview
2. Latin America Autologous Cell Therapy Product Market, 2016 - 2028 (USD Million)
3. Latin America Autologous Cell Therapy Product Market, by Source
  1. By Bone Marrow
  2. By Epidermis
4. Latin America Autologous Cell Therapy Product Market, by End User
  1. By Hospitals
  2. By Ambulatory Centers
  3. By Research Centers
5. Latin America Autologous Cell Therapy Product Market, by Application
  1. By Cancer
  2. By Neurodegenerative Diseases
  3. By Wound Healing
  4. By Orthopedic
  5. By CVD
  6. By Autoimmune Diseases
6. Latin America Autologous Cell Therapy Product Market, by Country
  1. Brazil
    1. Brazil Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. Brazil Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. Brazil Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
  2. Argentina
    1. Argentina Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. Argentina Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. Argentina Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
  3. Rest of Latin America
    1. Rest of Latin America Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. Rest of Latin America Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. Rest of Latin America Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
Middle East & Africa Autologous Cell Therapy Product Market - Segment Analysis
1. Overview
2. Middle East & Africa Autologous Cell Therapy Product Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Autologous Cell Therapy Product Market, by Source
  1. By Bone Marrow
  2. By Epidermis
4. Middle East & Africa Autologous Cell Therapy Product Market, by End User
  1. By Hospitals
  2. By Ambulatory Centers
  3. By Research Centers
5. Middle East & Africa Autologous Cell Therapy Product Market, by Application
  1. By Cancer
  2. By Neurodegenerative Diseases
  3. By Wound Healing
  4. By Orthopedic
  5. By CVD
  6. By Autoimmune Diseases
6. Middle East & Africa Autologous Cell Therapy Product Market, by Country
  1. GCC Countries
    1. GCC Countries Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. GCC Countries Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. GCC Countries Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
  2. South Africa
    1. South Africa Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. South Africa Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. South Africa Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Autologous Cell Therapy Product Market, By Source
      1. By Bone Marrow
      2. By Epidermis
    2. Rest of Middle East & Africa Autologous Cell Therapy Product Market, By End User
      1. By Hospitals
      2. By Ambulatory Centers
      3. By Research Centers
    3. Rest of Middle East & Africa Autologous Cell Therapy Product Market, By Application
      1. By Cancer
      2. By Neurodegenerative Diseases
      3. By Wound Healing
      4. By Orthopedic
      5. By CVD
      6. By Autoimmune Diseases
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Vericel Corporation (US)
2. Pharmicell Co. Inc(South Korea)
3. Holostem Terapie Avanzate S.R.L (Italy)
4. Lineage Cell Therapeutics Inc. (US)
5. Opexa Therapeutics (US)
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

Vantage Market Research | 24-Feb-2022

Autologous Cell Therapy Product Market Anticipated to Reach Valuation of USD 34.8 Billion by 2028

FAQ

Frequently Asked Question

What is the global demand for Autologous Cell Therapy Product in terms of revenue?

The global Autologous Cell Therapy Product valued at USD 11.69 Billion in 2022 and is expected to reach USD 40.77 Billion in 2030 growing at a CAGR of 16.90%.

Which are the prominent players in the market?

The prominent players in the market are Vericel Corporation (US), Pharmicell Co. Inc(South Korea), Holostem Terapie Avanzate S.R.L (Italy), Lineage Cell Therapeutics Inc. (US), Opexa Therapeutics (US).

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 16.90% between 2023 and 2030.

What are the driving factors fueling the growth of the market.

The driving factors of the Autologous Cell Therapy Product include
- Rising Government Investments in Cell-Based Research

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Autologous Cell Therapy Product in 2022.

Autologous Cell Therapy Product Market

Autologous Cell Therapy Product Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Autologous Cell Therapy Product in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Vantage Market Research

Products & Services

Media

Contact Us

Autologous Cell Therapy Product Market

Autologous Cell Therapy Product Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Autologous Cell Therapy Product in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Autologous Cell Therapy Product Market

Vantage Point Interactive Dashboard